Evidence item

The same report gives the combined assay’s 86.8% stage I–II sensitivity in the testing cohort. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 14273

Source: PANXEON Blood Test Detects Early Pancreatic Cancer · locator {} · excerpt hash sha256:26c5d726c3c20aaf79251cc38e5877598c3b06887b3559eb71aad879bc56d48a

For stage I–II pancreatic cancer, the combined approach reached a sensitivity of: 86.8%.